REGENERO

Regenero is a clinical-stage biotechnology company focused on developing advanced regenerative medicine solutions, particularly in the field of cell and secretome-based therapies. The company leverages its proprietary Regen-X platform to develop off-the-shelf, allogeneic products derived from mesenchymal stem cells (MSCs) and their exosomes. Their primary therapeutic focus includes musculoskeletal disorders such as osteoarthritis and degenerative disc disease, as well as vascular and wound healing applications. Regenero aims to provide scalable and standardized regenerative treatments that address significant unmet medical needs in chronic degenerative conditions.